APP lactylation was reduced in AD, and a lactyl-mimicking mutant, APPK612T, inhibited Aβ generation and slowed down memory decline in vivo, suggesting a neuroprotective role of APP-K612la in AD. Here, APP is linked to Alzheimer disease.